tiprankstipranks
Sutro Biopharma Inc (STRO)
NASDAQ:STRO
US Market
STRO
Sutro Biopharma
RESEARCH TOOLSreports

Sutro Biopharma (STRO) Income Statement

718 Followers

Sutro Biopharma Income Statement

Last quarter (Q4 2025), Sutro Biopharma's total revenue was $11.65M, a decrease of -21.35% from the same quarter last year. In Q4, Sutro Biopharma's net income was $-46.76M. See Sutro Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 102.48M$ 62.04M$ 153.73M$ 67.77M$ 61.88M
Gross Profit
$ 95.16M$ 54.83M$ 146.91M$ 59.48M$ 52.11M
Operating Expenses
$ 200.11M$ 293.28M$ 236.19M$ 188.43M$ 150.63M
Depreciation and Amortization
$ 7.32M$ 7.22M$ 6.82M$ 8.29M$ 4.84M
EBITDA
$ -97.63M$ -180.45M$ -67.92M$ -105.07M$ -97.56M
Operating Income
$ -104.95M$ -238.45M$ -89.28M$ -128.94M$ -98.52M
Other Income/Expenses
$ -86.23M$ 13.36M$ 677.00K$ 12.24M$ -7.01M
Pretax Income
$ -191.18M$ -225.10M$ -88.60M$ -116.70M$ -105.54M
Net Income
$ -191.09M$ -227.46M$ -106.79M$ -119.20M$ -105.54M
Per Share Metrics
Basic EPS
$ -22.49$ -29.60$ -17.80$ -23.50$ -22.90
Diluted EPS
$ -22.49$ -29.60$ -17.80$ -23.50$ -22.90
Weighted Average Shares Outstanding
 8.50M 7.68M 6.02M 5.07M 4.61M
Weighted Average Shares Outstanding (Diluted)
 8.50M 7.68M 6.02M 5.07M 4.61M
Currency in USD

Sutro Biopharma Earnings and Revenue History